Tower Research Capital (TRC)’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-195	Closed	-$2K	–	6577
2023 Q1	$2K	Sell	195 -2	-1%	-$21	﹤0.01%	5466
2022 Q4	$2K	Sell	197 -118	-37%	-$1.19K	﹤0.01%	5501
2022 Q3	$3K	Buy	315 +115	+58%	+$1.15K	﹤0.01%	5476
2022 Q2	$2K	Buy	+200	New	+$2K	﹤0.01%	5665

Tower Research Capital (TRC)'s LVAC Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 195 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in LVAC in Q2 2022 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Tower Research Capital (TRC) reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 195 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2K.
Tower Research Capital (TRC) first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Tower Research Capital (TRC)'s LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $3K in Q3 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.